Can Vinegar Help Diabetes?

February 26th, 2012

If you have type 2 diabetes, you may have heard that a spoonful of vinegar before or after a high-carb meal will prevent a blood sugar spike. Like most doctors you probably dismiss the claim as an old-wive’s tale, or a folk remedy with no scientific basis.

True, medicinal benefits of apple cider vinegar have been claimed for everything from arthritis to weight loss, asthma, colitis and food poisoning, in addition to claims for lowering blood sugar after high carbohydrate meal. (Published site)

American College of Physicians Now Recommends Metformin For Initial Type 2 Diabetes Treatment

February 21st, 2012

Several years ago the American Diabetes Association recommended diet and exercise as the initial treatment for type 2 diabetes. As well as that might work for most people, it is very difficult to stick with diet and exercise to maintain your blood sugar levels. The ADA acknowledged that reality some time ago and added to their guidelines starting newly diagnosed type 2 diabetes with metformin. (Published site)

Another week, another drug approved for type 2 diabetes

February 8th, 2012 

written by Michael O’Leary
If it seems there is another new drug given FDA approval for treatment of type 2 diabetes every week, you are not imaging things. Last week, once-a-week injection formula BYDUREON was approved.

This week the FDA approved another once-daily pill to help people with type 2 diabetes control their blood sugar levels. The new drug is a combination of sitagliptin and metformin and MERCK is marketing it under the brand name Janumet XR^®, the XR is for extended release. (Published site)

FDA Finally Approves Bydureon

February 6th, 2012 written by Michael O’Leary

Try, try again. After three tries BYDUREON, the once-a-week version of Byetta received FDA approval last Friday, Jan. 27. The approval follows two earlier rejections by the FDA, which each time asked for more data.

BYETTA® (exenatide) was developed by Amylin Pharmeceuticals and Eli Lily. The twice-daily injection drug was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. GLP-1 stimulates the release of insulin when glucose levels become too high. (Published site)